FDA Inspection 1153217 — Gillson Testing, Inc.
The FDA completed an inspection of Gillson Testing, Inc. on Sep 24, 2021 in Schnecksville, PA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Sep 24, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Schnecksville, PA (United States)